依托咪酯
医学
肾上腺功能不全
相对风险
荟萃分析
内科学
死亡率
重症监护
死亡风险
麻醉
重症监护医学
置信区间
异丙酚
作者
Stewart G. Albert,Sujata Sitaula
标识
DOI:10.1177/0885066620957596
摘要
Whereas etomidate causes adrenal insufficiency, it was not shown to increase mortality in many analyzed here in ICU settings. However, etomidate associated relative mortality rates increased progressively and correlated with the severity of critical illness scores. Intensivists should anticipate the need for glucocorticoid supplementation after etomidate in those with severe critical illness and in those with acute deterioration of vital signs.
科研通智能强力驱动
Strongly Powered by AbleSci AI